TENAX THERAPEUTICS,

TENX
Delayed Quote. Delayed  - 05/13 04:00:00 pm
2.01USD -4.29%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.

Number of employees : 9 people.
Managers
Name Title
Anthony A. DiTonno Chief Executive Officer & Director
Michael B. Jebsen President & Chief Financial Officer
Ronald R. Blanck Chairman
Stuart Rich Director & Chief Medical Officer
Doug Randall Executive VP-Commercial & Business Operations
Gregory Pepin Independent Director
Chris A. Rallis Independent Director
Gerald T. Proehl Independent Director
James P. Mitchum Independent Director
Steven Joseph Boyd Independent Director
Shareholders
Name Equities %
Armistice Capital LLC 2,019,995 13.9%
Stuart Rich 662,517 4.57%
BlackRock Fund Advisors 598,475 4.12%
Tang Capital Management LLC 460,000 3.17%
Renaissance Technologies LLC 427,032 2.94%
RA Capital Management LP 119,485 0.82%
Broadfin Capital LLC 98,432 0.68%
HealthCor Management LP 75,000 0.52%
Financial Advisory Service, Inc. 58,326 0.40%
Great Point Partners LLC 55,430 0.38%
Company contact information
Tenax Therapeutics, Inc.
ONE Copley Parkway
Suite 490
Morrisville, NC 27560

Phone : +1.919.855.2100
Fax : +1.919.855.2133
Web : http://www.tenaxthera.com
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
TENAX THERAPEUTICS, INC.12.90%31
MODERNA, INC.46.15%61 305
LONZA GROUP AG-1.83%45 649
IQVIA HOLDINGS INC.27.25%43 699
CELLTRION, INC.-26.18%31 675
SEAGEN INC.-17.34%26 272
CUREVAC N.V.15.90%21 497
HANGZHOU TIGERMED CONSULTING CO.,LTD-5.82%20 632
PHARMARON BEIJING CO., LTD.36.88%20 564
INCYTE CORPORATION-7.29%18 115
PPD, INC.34.66%16 173
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.28.27%15 918
BIO-TECHNE CORPORATION28.76%15 902
ALNYLAM PHARMACEUTICALS, INC.2.61%15 676
ICON PUBLIC LIMITED COMPANY15.02%11 855
PRA HEALTH SCIENCES, INC.35.62%11 023
QIAGEN N.V.-12.43%10 571
NOVAVAX, INC.14.63%9 467
SYNEOS HEALTH, INC.24.72%8 822
UNITED THERAPEUTICS CORPORATION28.79%8 757
ABCELLERA BIOLOGICS INC.-23.66%8 323